================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 29, 2003 BRISTOL-MYERS SQUIBB COMPANY (Exact Name of Registrant as Specified in its Charter) Delaware 1-1136 22-079-0350 (State or Other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification Number) 345 Park Avenue New York, NY, 10154 (Address of Principal Executive Office) Registrant's telephone number, including area code: (212) 546-4000 ================================================================================ Item 7. Financial Statements and Exhibit (c) Exhibit Exhibit 99 Press Release of Bristol-Myers Squibb Company dated April 29, 2003, reporting Bristol-Myers Squibb's financial results for the first quarter of 2003. Item 9. Regulation FD disclosure Incorporated by reference is a press release issued by the Registrant on April 29, 2003 regarding earnings for the first quarter of 2003, attached as Exhibit 99. This information is being furnished pursuant to Item 12 - Results of Operations and Financial Condition, on Form 8-K and is being presented under Item 9 of Form 8-K in accordance with interim guidance issued by the Securities and Exchange Commission in Release Nos. 33-8216 and 34-47583. This information is not deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into any Securities Act registration statements. SIGNATURE Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BRISTOL-MYERS SQUIBB COMPANY By: (s) Sandra Leung --------------------------------------- Sandra Leung Title: Vice President and Secretary Dated: April 29, 2003 EXHIBIT INDEX Exhibit No. Description 99 Press Release of Bristol-Myers Squibb Company dated April 29, 2003, reporting Bristol-Myers Squibb's financial results for the first quarter of 2003.